Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8954
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorGazdic, Marina-
dc.contributor.authorSimovic Markovic, Bojana-
dc.contributor.authorJovicic, Nemanja-
dc.contributor.authorMisirkic-Marjanovic M.-
dc.contributor.authorDjonov V.-
dc.contributor.authorJakovljevic V.-
dc.contributor.authorArsenijevic, Nebojsa-
dc.contributor.authorLukic, Miodrag-
dc.contributor.authorVolarevic, Vladislav-
dc.date.accessioned2020-09-19T17:06:18Z-
dc.date.available2020-09-19T17:06:18Z-
dc.date.issued2017-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8954-
dc.description.abstract© 2017 Marina Gazdic et al. Since majority of systemically administered mesenchymal stem cells (MSCs) become entrapped within the lungs, we used metastatic model of lung cancer, induced by intravenous injection of Lewis lung cancer 1 (LLC1) cells, to investigate the molecular mechanisms involved in MSC-mediated modulation of metastasis. MSCs significantly augmented lung cancer metastasis, attenuate concentrations of proinflammatory cytokines (TNF-α, IL-17), and increase levels of immunosuppressive IL-10, nitric oxide, and kynurenine in sera of LLC1-treated mice. MSCs profoundly reduced infiltration of macrophages, TNF-α-producing dendritic cells (DCs), TNF-α-, and IL-17-producing CD4+ T cells but increased IL-10-producing CD4+ T lymphocytes in the lungs of tumor-bearing animals. The total number of lung-infiltrated, cytotoxic FasL, perforin-expressing, TNF-α-, and IL-17-producing CD8+ T lymphocytes, and NKG2D-expressing natural killer (NK) cells was significantly reduced in LLC1 + MSC-treated mice. Cytotoxicity of NK cells was suppressed by MSC-conditioned medium. This phenomenon was abrogated by the inhibitors of inducible nitric oxide synthase (iNOS) and indoleamine 2,3-dioxygenase (IDO), suggesting the importance of iNOS and IDO for MSC-mediated suppression of antitumor cytotoxicity of NK cells. This study provides the evidence that MSCs promote lung cancer metastasis by suppressing antitumor immune response raising concerns regarding safety of MSC-based therapy in patients who have genetic susceptibility for malignant diseases.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceStem Cells International-
dc.titleMesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response-
dc.typearticle-
dc.identifier.doi10.1155/2017/6294717-
dc.identifier.scopus2-s2.0-85027240572-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

62

Downloads(s)

6

Files in This Item:
File Description SizeFormat 
10.1155-2017-6294717.pdf5.63 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons